Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice

[1]  C. Mori,et al.  Gut–microbiota–brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence , 2022, European Archives of Psychiatry and Clinical Neuroscience.

[2]  Yuko Fujita,et al.  Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota , 2022, Neuropharmacology.

[3]  Lijia Chang,et al.  Brain-spleen axis in health and diseases: A review and future perspective , 2022, Brain Research Bulletin.

[4]  Yuko Fujita,et al.  Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine , 2022, Translational Psychiatry.

[5]  K. Hashimoto,et al.  (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation , 2021, Psychopharmacology.

[6]  V. K. Rai,et al.  IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis. , 2021, Current drug research reviews.

[7]  B. Cheraghian,et al.  The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial , 2021, Nutrition Journal.

[8]  Yuko Fujita,et al.  Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice , 2021, Scientific Reports.

[9]  K. Hashimoto,et al.  Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor , 2021, Molecular Psychiatry.

[10]  N. Lin,et al.  Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells , 2021, Frontiers in Immunology.

[11]  A. Balato,et al.  Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis , 2021, The Lancet.

[12]  K. Hashimoto,et al.  Abnormalities of the composition of the gut microbiota and short-chain fatty acids in mice after splenectomy , 2021, Brain, behavior, & immunity - health.

[13]  T. Schwarz,et al.  Induction of regulatory T cells and correction of cytokine dysbalance by short chain fatty acids - Implications for the therapy of psoriasis. , 2020, The Journal of investigative dermatology.

[14]  K. Hashimoto,et al.  A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration , 2020, Translational Psychiatry.

[15]  A. Armstrong,et al.  Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. , 2020, JAMA.

[16]  K. Hashimoto.  Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. , 2020, Biochemical pharmacology.

[17]  Yuko Fujita,et al.  Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine , 2019, European Archives of Psychiatry and Clinical Neuroscience.

[18]  S. Werner,et al.  Tussilagonone ameliorates psoriatic features in keratinocytes and imiquimod-induced psoriasis-like lesions in mice via Nrf2 activation: Tussilagonone ameliorates psoriatic features. , 2019, The Journal of investigative dermatology.

[19]  Yan Wang,et al.  Study on the effect of spleen deficiency on the pathogenesis of psoriasis based on intestinal microbiome , 2019, Longhua Chinese Medicine.

[20]  S. Lewis,et al.  Structure and function of the immune system in the spleen , 2019, Science Immunology.

[21]  Adriana Rendon,et al.  Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.

[22]  Siyuan Li,et al.  Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury , 2018, Molecular medicine reports.

[23]  H. Woodrow,et al.  : A Review of the , 2018 .

[24]  K. Kingo,et al.  The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease , 2017, Archives of Dermatological Research.

[25]  J. Shieh,et al.  Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice. , 2016, Journal of dermatological science.

[26]  C. Zouboulis,et al.  Neuroendocrinology of the skin , 2016, Reviews in Endocrine and Metabolic Disorders.

[27]  P. Manna,et al.  On the role of skin in the regulation of local and systemic steroidogenic activities , 2015, Steroids.

[28]  M. Megna,et al.  Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. , 2015, World Journal of Gastroenterology.

[29]  Masanori Arita,et al.  MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis , 2015, Nature Methods.

[30]  Tian-yu Chen,et al.  Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis , 2014, Molecular medicine reports.

[31]  Emma L. Schymanski,et al.  Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.

[32]  F. Nestle,et al.  TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis , 2013, European journal of immunology.

[33]  M. Pittet,et al.  The spleen in local and systemic regulation of immunity. , 2013, Immunity.

[34]  D. Gladman,et al.  Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. , 2013, Journal of the American Academy of Dermatology.

[35]  S. Werner,et al.  Aldara activates TLR7-independent immune defence , 2013, Nature Communications.

[36]  E. Kontny,et al.  Taurine and inflammatory diseases , 2012, Amino Acids.

[37]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[38]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[39]  A. Slominski,et al.  Neuroendocrinology of the skin. , 2000, Endocrine reviews.

[40]  H. Rylance,et al.  SUBSTITUTED DIHYDROXYBENZOIC ACIDS AS POSSIBLE ANTI‐INFLAMMATORY AGENTS , 1963, The Journal of pharmacy and pharmacology.

[41]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[42]  B. Kollen,et al.  A Double-blind Randomized Controlled Trial , 2011 .

[43]  L. Ferguson,et al.  Role of gut microbiota in , 2009 .

[44]  Kevin G. Smith,et al.  On the use of spleen mass as a measure of avian immune system strength , 2003, Oecologia.